185 related articles for article (PubMed ID: 33446698)
1. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.
Peng T; Sun Y; Lv Z; Zhang Z; Su Q; Wu H; Zhang W; Yuan W; Zuo L; Shi L; Zhang LF; Zhou X; Mi Y
Sci Rep; 2021 Jan; 11(1):1373. PubMed ID: 33446698
[TBL] [Abstract][Full Text] [Related]
2. Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population.
Mansoor Q; Fayyaz S; Farooqi AA; Bhatti S; Ismail M
J Exp Ther Oncol; 2013; 10(3):215-7. PubMed ID: 24416997
[TBL] [Abstract][Full Text] [Related]
3. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
[TBL] [Abstract][Full Text] [Related]
4. Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
Brito LP; Lerário AM; Bronstein MD; Soares IC; Mendonca BB; Fragoso MC
J Clin Endocrinol Metab; 2010 Oct; 95(10):E271-9. PubMed ID: 20660043
[TBL] [Abstract][Full Text] [Related]
5. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.
Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009
[TBL] [Abstract][Full Text] [Related]
6. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.
Chen Q; Li WJ; Wan YY; Yu CD; Li WG
Genet Mol Res; 2012 Mar; 11(1):548-55. PubMed ID: 22535390
[TBL] [Abstract][Full Text] [Related]
8. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.
Zhu X; Zheng L; Asa SL; Ezzat S
Am J Pathol; 2010 Dec; 177(6):2860-9. PubMed ID: 21037081
[TBL] [Abstract][Full Text] [Related]
10. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
[TBL] [Abstract][Full Text] [Related]
12. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study.
Zhu Q; Liu T
Mol Biol Rep; 2012 Sep; 39(9):8679-85. PubMed ID: 22696188
[TBL] [Abstract][Full Text] [Related]
15. G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.
Jézéquel P; Campion L; Joalland MP; Millour M; Dravet F; Classe JM; Delecroix V; Deporte R; Fumoleau P; Ricolleau G
Br J Cancer; 2004 Jan; 90(1):189-93. PubMed ID: 14710228
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
[TBL] [Abstract][Full Text] [Related]
18. Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.
Ulaganathan VK; Sperl B; Rapp UR; Ullrich A
Nature; 2015 Dec; 528(7583):570-4. PubMed ID: 26675719
[TBL] [Abstract][Full Text] [Related]
19. FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
Levine KM; Ding K; Chen L; Oesterreich S
Pharmacol Ther; 2020 Oct; 214():107590. PubMed ID: 32492514
[TBL] [Abstract][Full Text] [Related]
20. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.
FitzGerald LM; Karlins E; Karyadi DM; Kwon EM; Koopmeiners JS; Stanford JL; Ostrander EA
Prostate Cancer Prostatic Dis; 2009; 12(2):192-7. PubMed ID: 18762813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
